http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014181107-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b0c198757da18cf77dfbdcef00abb70
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d5a6abe56a5074d44cd16ac67ace2c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80fea1e667af134366297162079a1ae
publicationDate 2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014181107-A1
titleOfInvention Genetic method of aiding the diagnosis and treatment of familial hypercholersterolaemia
abstract The invention relates to a method for collecting information useful in aiding the diagnosis and treatment of familial hypercholesterolaemia (FH), the method comprising providing a sample of DNA from the subject, assaying said DNA for (i) mutation in one or more genes which is indicative of FH diagnosis (ii) presence of one or more SNPs indicative of incremental risk of high cholesterol; and (iii) mutation in a gene which is indicative of likelihood of statin toxicity; wherein assaying said DNA comprises the step of contacting said DNA sample with one or more primers for amplification and/or sequencing of the relevant segment(s) of said DNA characterised in that each of said assays of steps (i), (ii) and (iii) is carried out in a single assay cycle. The invention also relates to a method of treatment, and to primers.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110592185-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113684269-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113684270-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110295224-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109055527-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105803099-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109251977-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113584146-A
priorityDate 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011027219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683195-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5455166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005072151-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5270184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683202-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5409818-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013043041-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683202-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129333138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11865464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915

Total number of triples: 43.